Vaccine center gets $22 million contract

August 23, 2002

The University of Maryland's Center for Vaccine Development in Baltimore has been awarded a $22 million federal research contract to study new vaccines against diseases ranging from anthrax and smallpox to meningitis and malaria.

The grant, from the National Institute of Allergy and Infectious Diseases, is the second-largest awarded to the university's School of Medicine, where the research center is based.

Under the five-year contract, researchers will test the effectiveness of new vaccines as well as determine why some people respond better than others to them.

Baltimore Sun Articles
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.